
Group Dinner Meeting to be held in London, England on November 16 hosted by B. Riley. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ZYME | Zymeworks | 26.14 | 2.12 | 8.83% |
| Name | Price | % Change | |
|---|---|---|---|
| $26.14 | +8.83% |

Group Dinner Meeting to be held in London, England on November 16 hosted by B. Riley. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

Zymeworks ( ($ZYME) ) has shared an announcement. Zymeworks is a global biotechnology company building a diversified portfolio of healthcare assets while advancing innovative medicines for difficult-to-treat diseases. Its portfolio

Zymeworks (ZYME) announced that its Board of Directors has authorized a second 2026 share repurchase program under which the company may repurchase up to $200M of its outstanding common stock.

Citizens analyst Reni Benjamin raised the firm’s price target on Zymeworks (ZYME) to $39 from $32 and keeps an Outperform rating on the shares. The firm’s outlook is supported by

Citi raised the firm’s price target on Zymeworks (ZYME) to $44 from $39 and keeps a Buy rating on the shares. The company upped its 2026 revenue guidance to reflect

Reports Q3 revenue $256.46M, consensus $221.01M. “We are entering the next phase of Zymeworks (ZYME) growth with a fundamentally stronger and more diversified business. The transformation of Zymeworks is becoming

H.C. Wainwright raised the firm’s price target on Zymeworks (ZYME) to $56 from $55 and keeps a Buy rating on the shares following the Q3 report. Published first on TheFly

TD Cowen raised the firm’s price target on Zymeworks (ZYME) to $39 from $34 and keeps a Buy rating on the shares. The company raised FY26 revenues and adjusted EBITDA

Zymeworks ( ($ZYME) ) has provided an update. On November 9, 2026, Zymeworks reported financial results for the quarter ended September 30, 2026, and raised its 2026 guidance. Total revenue

Zymeworks (ZYME) is scheduled to report 3rd quarter earnings on 11/09/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Zymeworks to post earnings of $2.27 per share.
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 18, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 12, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Oct 29, 2026 | ||||
| buy | Reiterated | Oct 28, 2026 | ||||
| buy | Reiterated | Oct 23, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 10, 2027TBA | $1.86B | $0.13 | $72.50M | 0.73 | 39.01 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.